IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the third quarter ended September 30, 2023, including a corporate update on Wednesday, November 8, 2023, after market.

Management will host a conference call on November 8 at 5:00 pm ET. A live webcast will be available on the "Events and Presentations" section of ReShape's website at:

To access the call by phone, please register with the ...

Full story available on